We observed a consistent positivity for SOX11 in the IDH1mt subset of diffuse gliomas (n = 34, Figure 3A), and IDH1mt tumours showed significantly higher expression of SOX11 when compared to glioblastomas (median mHS 2 vs. 25.8, p < 0.001, MW). This evidence concerns the gene SOX11 and glioblastoma.